Liberia vs Rwanda: Access to anti-retroviral drugs, female
Liberia
96.0%
in 2024
Rwanda
97.0%
in 2024
Liberia rank
14th
Rwanda rank
12th
Access to anti-retroviral drugs, female over time
- Liberia
- Rwanda
How they compare
Rwanda currently reports 97.0% against 96.0% in Liberia, a difference of 1.0%.
Across all 25 years both countries report, Rwanda has been ahead every year.
Liberia ranks 14th and Rwanda ranks 12th of 141 countries.
Rwanda has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Liberia | Rwanda | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.7% | 11.1% | 9.4% | Rwanda |
| 2010s | 27.4% | 63.3% | 35.9% | Rwanda |
| 2020s | 77.2% | 90.8% | 13.6% | Rwanda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Liberia or Rwanda?
- Rwanda, at 97.0% against 96.0% in Liberia as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Liberia and Rwanda?
- 1.0%, with Rwanda ahead.
- How many years of comparable data are there for Liberia and Rwanda?
- 25 years are reported by both, from 2000 to 2024.
- How do Liberia and Rwanda rank globally for access to anti-retroviral drugs, female?
- Liberia ranks 14th and Rwanda ranks 12th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.